Literature DB >> 3300078

Absorption of Mycobacterium bovis BCG administered by the oral route.

R C Mortatti, L C Maia, L S Fonseca.   

Abstract

The action of gastric and duodenal juices on BCG as well as on its absorption and its distribution in the organs after intragastric administration in mice were studied. A significant decrease in BCG oxygen uptake and a moderate loss of viability were found after 2 h treatment with gastric juice. Using duodenal juice, a marked decrease of respiration and a notable fall in viability were observed. Labelling of BCG with carbon-14 was accomplished using [14C]glycerol as a precursor of mycobacterial lipids. Similar levels of radioactivity were recovered in organs of mice 24 h after intragastric administration of 14C-BCG, sonicated 14C-BCG and [14C]glycerol. The level of 14C-BCG remained stable from 6 to 24 days, while sonicated 14C-BCG and [14C]glycerol defined a biological decay process. Studies of biological decay from the small intestine and liver indicated that the absorptive process started rapidly and reached its highest level at 24 h, declining thereafter according to the complexity of the material given to mice. However, living bacilli were not cultured from organs of mice given single doses of unlabelled BCG. Therefore, judging from the above data it may be concluded that the majority of BCG bacilli absorbed intact were not alive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300078     DOI: 10.1016/0264-410x(87)90056-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction.

Authors:  J M Dumonceau; A Van Gossum; M Adler; J P Van Vooren; P A Fonteyne; H De Beenhouwer; F Portaels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 2.  Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.

Authors:  Yuan-qiang Zheng; Youssef W Naguib; Yixuan Dong; Yan-chun Shi; Shorgan Bou; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2015       Impact factor: 5.217

3.  Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.

Authors:  Gareth A Williams; Marjorie E Koenen; Robert Havenaar; Paul Wheeler; Sonya Gowtage; Sandrine Lesellier; Mark A Chambers
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

4.  Detection of live M. bovis BCG in tissues and IFN-γ responses in European badgers (Meles meles) vaccinated by oropharyngeal instillation or directly in the ileum.

Authors:  Sandrine Lesellier; Maria-Laura Boschiroli; Jacques Barrat; Christoph Wanke; Francisco J Salguero; Waldo L Garcia-Jimenez; Alex Nunez; Ana Godinho; John Spiropoulos; Simonette Palmer; Dipesh Dave; Paul Anderson; Jean-Marc Boucher; Krystel de Cruz; Sylvie Henault; Lorraine Michelet; Sonya Gowtage; Gareth A Williams; Allan K Nadian; Elodie Monchâtre-Leroy; Frank Boué; Mark A Chambers; Céline Richomme
Journal:  BMC Vet Res       Date:  2019-12-06       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.